Coupling Genotyping and Computational Modeling in Prediction of Anti-epileptic Drugs that cause Stevens Johnson Syndrome and Toxic Epidermal Necrolysis for Carrier of HLA-B*15:02
Purpose. The importance of HLA-B*15:02 genotyping to avoid carbamazepine induced SJS/TEN and molecular modeling to predict the role of HLA-B*15:0 and AEDs induced SJS/TEN are investigated. Methods. DNA was extracted from eighty-six patients. The patients were genotyped by AS-PCR. Computational mode...
Main Authors: | Lay Kek Teh, Manikandan Selvaraj, Zakaria Bannur, Mohd Ikhwan Mohd Ismail, Hanip Rafia, Wan Chung Law, Sapiah Sapuan, Santhi Puvanarajah, Pakeer Shaik Syed Ali, Mohd Zaki Salleh |
---|---|
Format: | Article |
Language: | English |
Published: |
Canadian Society for Pharmaceutical Sciences
2016-03-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/25678 |
Similar Items
-
Coupling genotyping and computational modeling in prediction of antiepileptic drugs that cause Stevens Johnson syndrome and toxic epidermal Necrolysis for carrier of HLA-B*15:02
by: Ali, P.S.S, et al.
Published: (2016) -
Toxic epidermal necrolysis and Stevens-Johnson syndrome
by: French Lars E, et al.
Published: (2010-12-01) -
Epidermal necrolysis (Stevens–Johnson syndrome and toxic epidermal necrolysis): Historical considerations
by: Jean-Claude Roujeau
Published: (2013-12-01) -
Stevens-Johnson syndrome and toxic epidermal necrolysis in children
by: Sudip Das, et al.
Published: (2018-01-01) -
Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum for the rheumatologist
by: Jyoti Ranjan Parida, et al.
Published: (2019-01-01)